Synopsys, Inc (1SNPS) Fair Value & Analysis
Technology · IT · Market cap €74.6B
Fair value as of: Jul 3, 2026
From 24 valuation models · updated 17 days ago
Share price −16.2% over the past month.
Price vs Fair Value (12 months)
12‑month range €329.50 – €562.40 · fair‑value band €88.71 – €147.85 · the €331.50 price screens above the €118.28 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Synopsys, Inc (1SNPS) currently trades at €331.50, while our model-based Fair Value estimate is €118.28, implying the stock looks roughly 64.3% overvalued today. We read business quality at 30/100 (below-average quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Synopsys, Inc generated revenue of €8.7B at a net margin of 8.9%. Revenue grew 41.9% year over year. It earns a return on equity of 3.8%. Net debt stands at €10.6B. Fundamentals as of Jul 3, 2026
Our scenario range runs from €88.71 (bear case) to €147.85 (bull case); at €331.50, the current price sits above that range. The share trades about 41% below its 52-week high and 2% above its 52-week low, currently below its 200-day average. For context, the median of 10 Technology peers we cover trades at -39% fair-value upside, at -64%, 1SNPS screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Synopsys, Inc. provides design IP solutions in the semiconductor and electronics industries. It operates in two segments, Design Automation and Design IP. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; FPGA design products that are programmed to perform specific functions; synopsys technology computer-aided design (TCAD), mask synthesis, and manufacturing analytic solutions; and AI-driven EDA solutions. It also provides pre-verified and silicon-proven IP solutions, logic libraries and embedded memories, processor and security solutions, IP Offerings for the automotive market, SOC infrastructure IP, data path and building block IP, and mathematical and floating-point components. Synopsys, Inc. has a strategic collaboration with Arm …
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
Synopsys, Inc reported revenue of €7.1B in FY2025 versus €4.6B in FY2022, a compound +15.2%/yr. Reported net income was €1.3B in FY2025, compounding +10.6%/yr from FY2022.
Is 1SNPS fairly valued? → Check now
Similar stocks
10 more Software - Infrastructure stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Microsoft Corporation MSFT | $395.77 | $242.64 | -39% |
| Oracle Corporation ORAC | C$9.08 | C$4.17 | -54% |
| Palantir Technologies Inc 1PLTR | €112.86 | €12.03 | -89% |
| Palo Alto Networks, Inc 5AP | €227.65 | €26.66 | -88% |
| Fortinet, Inc FTNT | $145.39 | $70.91 | -51% |
| Block, Inc XYZ | A$97.40 | A$75.22 | -23% |
| CoreWeave, Inc CRWV | $95.61 | $4.99 | -95% |
| VeriSign, Inc VRSN34 | R$373.00 | R$268.24 | -28% |
| F5, Inc F1FI34 | R$479.00 | R$416.56 | -13% |
| Corpay, Inc CPAY34 | R$386.10 | R$492.61 | +28% |
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is Synopsys, Inc (1SNPS) undervalued?
What is the fair value of 1SNPS?
What is the quality score of 1SNPS?
What is the revenue of Synopsys, Inc (1SNPS)?
What is the net profit margin of 1SNPS?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Synopsys, Inc analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.